Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes (LEO) Cohort

被引:0
|
作者
Bommier, Come [1 ,2 ]
Tsang, Mazie [3 ]
Noble, Brie N. [4 ]
Thompson, Carrie [5 ]
Casulo, Carla [6 ]
Hildebrandt, Michelle [7 ]
Rosenthal, Allison C. [8 ]
Mou, Eric [9 ]
Durani, Urshila [5 ]
Williams, Annalynn M. [10 ]
Yost, Kathleen [11 ]
Larson, Melissa C. [1 ]
Gysbers, Brianna [12 ]
Maurer, Matthew J. [13 ]
Feldman, Andrew L. [14 ]
Jaye, David L. [15 ]
Martin, Peter [16 ]
Cohen, Jonathon B. [17 ]
Chihara, Dai [18 ]
Lossos, Izidore S. [19 ]
Strouse, Christopher [20 ]
Kahl, Brad S. [21 ]
Habermann, Thomas M. [5 ]
Flowers, Christopher R.
Dueck, Amylou Constance [4 ]
Cerhan, James R. [13 ]
机构
[1] Mayo Clin, Div Epidemiol, Rochester, MN USA
[2] Univ Paris Cite, Hematol Oncol, Hop St Louis, Inserm U1153, Paris, France
[3] Mayo Clin, Phoenix, AZ USA
[4] Mayo Clin, Scottsdale, AZ USA
[5] Mayo Clin, Div Hematol, Rochester, MN USA
[6] Univ Rochester, Wilmot Canc Ctr, Rochester, NY USA
[7] Univ Texas MD Anderson Canc Ctr Houston, Houston, TX USA
[8] Mayo Clin, Div Hematol & Med Oncol, Phoenix, AZ USA
[9] Univ Iowa, Div Hematol Oncol & Blood Marrow Transplantat, Iowa City, IA USA
[10] Univ Rochester, Rochester, NY USA
[11] Mayo Clin, Div Epidemiol, Dept Quantitat Hlth Sci, Rochester, MN USA
[12] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[13] Mayo Clin, Dept Quantitat Hlth Sci, Rochester, MN USA
[14] Mayo Clin, Div Hematopathol, Dept Lab Med & Pathol, Rochester, MN USA
[15] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA USA
[16] Weill Cornell Med, Div Hematol & Med Oncol, New York, NY USA
[17] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[18] Univ Texas MD Anderson Canc Ctr Houston, Dept Lymphoma & Myeloma, Houston, TX USA
[19] Univ Miami, Div Hematol, Sylvester Comprehens Canc Ctr, Sch Med, Miami, FL USA
[20] Univ Iowa Hosp & Clin, Div Hematol, Holden Comprehens Canc Ctr, Oncol & Blood Marrow Transplantat, Iowa City, IA USA
[21] Washington Univ St Louis, Sch Med, St Louis, MO USA
关键词
D O I
10.1182/blood-2023-187056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 44 条
  • [21] Impact of comorbidity on health-related quality of life in newly diagnosed patients with lymphoma or multiple myeloma: results from the PROFILES-registry
    Ekels, Afke
    van de Poll-Franse, Lonneke V.
    Issa, Djamila E.
    Hoogendoorn, Mels
    Nijziel, Marten R.
    Koster, Adrianus
    de Jong, Cornelis N.
    Achouiti, Ahmed
    Thielen, Noortje
    Tick, Lidwine W.
    te Boome, Liane C. J.
    Bohmer, Lara H.
    Tiren-Verbeet, Nicolette L.
    Veldhuis, Gerrit J.
    de Boer, Fransien
    van der Klift, Marjolein
    Posthuma, Eduardus F. M.
    Oerlemans, Simone
    ANNALS OF HEMATOLOGY, 2024, 103 (12) : 5511 - 5525
  • [22] Employment status and health related quality of life among Hodgkin-lymphoma survivors'-results based on data from a major treatment center in Hungary
    Magyari, Ferenc
    Kosa, Karolina
    Berecz, Roland
    Illes, Anna
    Miltenyi, Zsofia
    Simon, Zsofia
    Illes, Arpad
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2017, 15
  • [23] Employment status and health related quality of life among Hodgkin-lymphoma survivors’– results based on data from a major treatment center in Hungary
    Ferenc Magyari
    Karolina Kósa
    Roland Berecz
    Anna Illés
    Zsófia Miltényi
    Zsófia Simon
    Árpád Illés
    Health and Quality of Life Outcomes, 15
  • [24] HEALTH-RELATED QUALITY OF LIFE AND ECONOMIC BURDEN IN CHINESE PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA (CTCL) - RESULTS FROM INTERIM ANALYSIS
    Shi, Y.
    Wang, Y.
    Sun, J.
    Sun, H.
    Zhang, M.
    Li, Z.
    Zhao, H.
    Xie, L.
    Huang, W.
    Yan, X.
    Du, X.
    Li, X.
    Jin, H.
    VALUE IN HEALTH, 2023, 26 (06) : S324 - S325
  • [25] Health-related quality of life outcomes associated with zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: results from the ALPINE Trial
    Tam, Constantine S.
    Lamanna, Nicole
    O'Brien, Susan M.
    Qiu, Lugui
    Yang, Keri
    Barnes, Gisoo
    Wu, Ken
    Salmi, Tommi
    Brown, Jennifer R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (11) : 1497 - 1503
  • [26] Two years rituximab maintenance vs. observation after first line treatment with bendamustine plus rituximab (B-R) in patients with marginal zone lymphoma (MZL): Results of a prospective, randomized, multicenter phase 2 study (the StiL NHL7-2008 MAINTAIN trial).
    Rummel, Mathias J.
    Koenigsmann, Michael
    Chow, Kai Uwe
    Knauf, Wolfgang
    Lerchenmuller, Christian A.
    Losem, Christoph
    Goerner, Martin
    Hertenstein, Bernd
    Decker, Thomas
    Ganser, Arnold
    Gaska, Tobias
    Heike, Michael
    Lange, Elisabeth
    Weide, Rudolf
    Willenbacher, Wolfgang
    Burchardt, Alexander
    Kauff, Frank
    Barth, Juergen
    Hinke, Axel
    Greil, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [27] Efficacy and quality of life (QoL) in patients with mycosis fungoides cutaneous T-cell lymphoma (MF-CTCL) treated with chlormethine gel and other therapies: results from the PROVe study
    Kim, E. J.
    Geskin, L. J.
    Querfeld, C.
    Girardi, M.
    Mink, D. R.
    Williams, M. J.
    Angello, J. T.
    Bailey, W. L.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S39 - S39
  • [28] Two years Rituximab maintenance vs. observation after first line treatment with bendamustine plus rituximab (B-R) in patients with marginal zone lymphoma (MZL): results of a prospective, randomized, multicenter phase 2 study (the StiL NHL7-2008 MAINTAIN trial)
    Rummel, M.
    Koenigsmann, M.
    Chow, K. U.
    Knauf, W.
    Lerchenmueller, C. A.
    Losem, C.
    Goerner, M.
    Hertenstein, B.
    Decker, T.
    Ganser, A.
    Gaska, T.
    Heike, M.
    Lange, E.
    Weide, R.
    Willenbacher, W.
    Burchardt, A.
    Kauff, F.
    Barth, J.
    Hinke, A.
    Greil, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 253 - 253
  • [29] Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study
    van der Meulen, M.
    Bakunina, K.
    Nijland, M.
    Minnema, M. C.
    Cull, G.
    Stevens, W. B. C.
    Baars, J. W.
    Mason, K. D.
    Beeker, A.
    Beijert, M.
    Taphoorn, M. J. B.
    van den Bent, M. J.
    Issa, S.
    Doorduijn, J. K.
    Bromberg, J. E. C.
    Dirven, L.
    ANNALS OF ONCOLOGY, 2020, 31 (08) : 1046 - 1055
  • [30] Health-related quality of life of survivors of non-Hodgkin's lymphoma: Results from the Experience of Care and Health Outcomes of Survivors of NHL (ECHOS-NHL) study
    Arora, NK
    Bellizzi, KM
    Rowland, JH
    Potosky, A
    Aziz, N
    Hamilton, A
    PSYCHO-ONCOLOGY, 2006, 15 (01) : S22 - S23